1. Home
  2. VERA vs TILE Comparison

VERA vs TILE Comparison

Compare VERA & TILE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$55.40

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Interface Inc.

TILE

Interface Inc.

HOLD

Current Price

$28.30

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERA
TILE
Founded
2016
1973
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
VERA
TILE
Price
$55.40
$28.30
Analyst Decision
Strong Buy
Buy
Analyst Count
11
1
Target Price
$76.60
$32.00
AVG Volume (30 Days)
1.9M
361.0K
Earning Date
11-05-2025
10-31-2025
Dividend Yield
N/A
0.28%
EPS Growth
N/A
33.41
EPS
N/A
1.92
Revenue
N/A
$1,372,471,000.00
Revenue This Year
N/A
$7.47
Revenue Next Year
N/A
$4.74
P/E Ratio
N/A
$14.74
Revenue Growth
N/A
5.11
52 Week Low
$18.53
$17.24
52 Week High
$56.05
$30.20

Technical Indicators

Market Signals
Indicator
VERA
TILE
Relative Strength Index (RSI) 82.73 58.81
Support Level $47.22 $27.87
Resistance Level $51.19 $29.09
Average True Range (ATR) 2.94 0.79
MACD 0.63 -0.02
Stochastic Oscillator 97.57 60.00

Price Performance

Historical Comparison
VERA
TILE

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About TILE Interface Inc.

Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.

Share on Social Networks: